Nacher M, Adenis A, Adriouch L, Dufour J, Papot E, Hanf M, Vantilcke V, Calvez M, Aznar C, Carme B, Couppie P, 2011. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg 84: 239–240.
Hanf M, Adenis A, Couppie P, Carme B, Nacher M, 2010. HIV-associated histoplasmosis in French Guiana: recent infection or reactivation? AIDS 24: 1777–1778.
Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, 2007. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45: 807–825.
May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, Dunn D, Palfreeman A, Gilson R, Gazzard B, Hill T, Walsh J, Fisher M, Orkin C, Ainsworth J, Bansi L, Phillips A, Leen C, Nelson M, Anderson J, Sabin C, 2011. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 343: d6016.
McKinsey DS, 1998. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS 12: 775–781.
World-Bank, 1993. World Development Report. Bank W, ed. Washington DC. Available at: http://wdronline.worldbank.org/worldbank/a/c.html/world_development_report_1993/abstract/WB.0-1952-0890-0.abstract1.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 34 | 33 | 8 |
Full Text Views | 259 | 89 | 0 |
PDF Downloads | 64 | 22 | 0 |
Histoplasmosis is the first cause of acquired immunodeficiency syndrome (AIDS) and AIDS-related deaths in French Guiana. Cohort data were used to determine whether primary prophylaxis with 100 mg itraconazole for patients with CD4 counts < 150/mm3 was cost-effective with different scenarios. For a scenario where 12% of patients died, 60% were aware of their human immunodeficiency virus (HIV) infection and adherence was only 50%, primary prophylaxis would prevent 1 death and 9 cases of histoplasmosis for a cost of 36,792 Euros per averted death, 1,533 per life-year saved, 4,415 Euros per averted case, when only counting the costs of itraconazole prophylaxis. Taking into account the total costs of hospitalization showed that primary prophylaxis would allow a savings of 185,178 Euros per year. Even in a scenario of low adherence, primary prophylaxis would be cost-effective in French Guiana, and presumably in the rest of the Guianas and the Amazon.
Authors' addresses: Mathieu Nacher and Antoine Adenis, Cayenne General Hospital - Centre d'Investigation Clinique Epidémiologie Clinique Antilles Guyane, Cayenne, French Guiana, E-mails: Mathieu.nacher@ch-cayenne.fr and antoine.adenis@ch-cayenne.fr. Celia Basurko, Centre Hospitalier de Cayenne - Centre d'Investigation Clinique, Epidémiologie Clinique Antilles Guyane, Cayenne, French Guiana, E-mail: celia.basurko@ch-cayenne.fr. Vincent Vantilcke, Centre Hospitalier de l’Ouest Guyanais - Service de Médecine, Saint Laurent du Maroni, French Guiana, E-mail: v.vantilcke@ch-ouestguyane.fr. Denis Blanchet, Centre Hospitalier de Cayenne - Laboratoire Hospitalo Universitaire de Parasitologie Mycology, Cayenne, French Guiana, E-mail: denis.blanchet@ch-cayenne.fr. Christine Aznar, Centre Hospitalier de Cayenne - Service Hospitalo Universitaire de Parasitologie Mycologie, Cayenne, French Guiana, E-mail: christine.aznar@ch-cayenne.fr. Bernard Carme, Centre d'Investigation Clinique épidémiologie Clinique Antilles Guyane, CIE INSERM 802 - Pole de Guyane, Centre Hospitalier de Cayenne, Cayenne, French Guiana, E-mail: bernard.carme@ch-cayenne.fr. Pierre Couppié, Universite des Antilles et de la Guyane - Equipe EA 3593, Epidemiologie des Parasitoses et Mycoses Tropicales, Cayenne, French Guiana, E-mail: couppie.pierre@voila.fr.
Nacher M, Adenis A, Adriouch L, Dufour J, Papot E, Hanf M, Vantilcke V, Calvez M, Aznar C, Carme B, Couppie P, 2011. What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. Am J Trop Med Hyg 84: 239–240.
Hanf M, Adenis A, Couppie P, Carme B, Nacher M, 2010. HIV-associated histoplasmosis in French Guiana: recent infection or reactivation? AIDS 24: 1777–1778.
Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, 2007. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45: 807–825.
May M, Gompels M, Delpech V, Porter K, Post F, Johnson M, Dunn D, Palfreeman A, Gilson R, Gazzard B, Hill T, Walsh J, Fisher M, Orkin C, Ainsworth J, Bansi L, Phillips A, Leen C, Nelson M, Anderson J, Sabin C, 2011. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 343: d6016.
McKinsey DS, 1998. Histoplasmosis in AIDS: advances in management. AIDS Patient Care STDS 12: 775–781.
World-Bank, 1993. World Development Report. Bank W, ed. Washington DC. Available at: http://wdronline.worldbank.org/worldbank/a/c.html/world_development_report_1993/abstract/WB.0-1952-0890-0.abstract1.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 34 | 33 | 8 |
Full Text Views | 259 | 89 | 0 |
PDF Downloads | 64 | 22 | 0 |